Saturday, November 16, 2019
Ocular Manifestations of Mucopolysacchridosis
Ocular Manifestations of Mucopolysacchridosis    Ocular manifestations of mucopolysacchridosis  Praddep Sagar Arsikere, Pradeep Venkatesh, Yog Raj Sharma  Mucopolysaccharidosesà  (MPS)à  are a group of disorders caused byà  theà  inherited deficiency of lysosomal enzymes involved inà  theà  metabolism of glycosaminoglycanà  (GAG),à  resulting inà  theà  widespread intracellular and extracellular accumulation ofà  GAG.à  >    Type    Gene    Deficient enzyme    GAG deposited    IInheritanceà  pattern    Hurler syndrome (MPS I-H)    IDUA (4p16.3)    Alpha-L-iduronidase    Dermatan sulfate, heparan sulfate    AR    Hurler-Scheie syndromeà  (MPS I-H/S)    IDUA (4p16.3)    Alpha-L-iduronidase    Dermatan sulfate, heparan sulfate    AR    Scheie syndrome (MPS I-S)    IDUA (4p16.3)    Alpha-L-iduronidase    Dermatan sulfate, heparan sulfate    AR    Hunter syndrome, severe (MPS II-A)    IDS  (Xq28)    Iduronate sulfatase    Dermatan sulfate, heparan sulfate    XR    Hunter syndrome, mild (MPS II-B)    IDS  (Xq28)    Iduronateà  sulfatase    Dermatan sulfate, heparan sulfate    XR    Sanfilippo syndrome A (MPS III-A)    SGSH (17q25.3)    Heparanà  N-sulfatase    Heparan sulfate    AR    Sanfilippo syndrome B (MPS III-B)    NAGLU (17q21)    Alpha-N-acetylglucosaminidase    Heparan sulfate    AR    Sanfilippo syndrome C (MPS III-C)    HGSNAT (8p11.1)    Heparan-alpha-glucosaminide Nacetyltransferase    Heparan sulfate    AR    Sanfilippo syndrome D (MPS III-D)    GNS  (12q14)    N-acetyl alpha-glucosamine-6-sulfatase    Heparan sulfate    AR    Morquio syndrome A (MPS IV-A)    GALNS (16q24.3)    N-acetylgalactosamine 6-sulfatase    Keratan sulfate    AR    Morquio syndrome B (MPS IV-B)    GLB1 (3p21.33)    Beta-galactosidase    Keratan sulfate    AR    Maroteaux-Lamy syndrome (MPS VI)    ARSB (5q14.1)    Arylsulfatase B    Dermatan sulfate    AR    Sly syndrome (MPS VII)    GUSB (7q21.11)    Beta-glucuronidase    Dermatan sulfate, heparan sulfate, Chondroitin sulfate    AR    Natowicz syndromeà  (MPS IX)    HYAL1  (3p21)    Hyaluronidase    AR    Ocular manifestations  1. Ocular adnexa  Eyelid thickeningà  occursà  due toà  theà  accumulation ofà  GAG. Hypertelorism has been reported in MPS typesà  III,à  Ã  II andà  Ã  VII. Pseudoproptosis due to shallow orbit has been reported in a patient with MPS VIà  and MPS II.  2. Cornea  The extracellular matrix of corneal stroma contains dermatan sulfate and keratan sulfate in equal proportion. Both dermatan sulfate and keratan sulfate are synthesized by stromal keratocytes. Dermatan sulfate proteoglycans are involved inà  theà  control of interfibrillar spacing and inà  theà  lamellar adhesion of corneal collagens. Keratan sulfate proteoglycans are involved in the regulation of collagen fibril diameter. Mainly,à  epithelial cells synthesize heparan sulfate proteoglycans,à  and they are minor components of cornea.  Since dermatan sulfate and keratan sulfate are the major GAGs inà  theà  corneal stroma, corneal involvement is mainly seen in MPS typesà  I, IV, VI and VII. In corneas of patients with MPS,à  theà  excessive accumulation of dermatan sulfate or keratan sulfate in the form of vacuoles can be seen in epithelial cells, keratocytes, histiocytes and extracellular matrix. An increase inà  theà  mean fibril diameter of collagen andà  anà  increase in fibril spacingà  areà  noted in the corneal stroma of patients with MPS I. These structural alterations in collagen fibrils may contribute to light scattering. But the corneal clouding is mainly due toà  theà  accumulation of GAGs in all the layers of cornea with enlarged stromal keratocytes.  Corneal involvement is typically not seen in type III, as the metabolism of heparan sulfate is impaired in type III and heparan sulfate is not synthesized by stromal keratocytes.  Symptoms include gradually progressive painless diminution of visual acuity and light intolerance due to scattering of light. In early cases, fine grey punctuate opacities in anterior stroma are visible. In advanced cases,à  there is diffuse corneal clouding. Corneal thickness is variable, and it may be increased or normal.à  Corneal hysteresis is increased. Cornealà  oedemaà  occurs in cases withà  increased intra-ocularà  pressureà  (IOP).  3.à  Optic nerve  GAGsà  are the major components ofà  theà  extracellular matrix ofà  theà  optic nerve head.à  Proteoglycans containing chondritin sulfate and dermatan sulfate are located in lamina cribrosa, supporting tissues of the optic nerve head like septae, pia. Proteoglycans containing heparan sulfate are located in margins of laminar plates of lamina cribrosa.à  Theà  optic nerve involvement can be due to accumulation ofà  Ã  GAGà  inà  theà  extracellular matrix ofà  theà  optic nerve, narrowing of pores in lamina cribrosa, thickening of duraà  andà  narrowing of bony optic canalà  Ã  thatà  leadsà  to discà  oedemaà  (pseudopapilloedema). It can also be due to raised intracranial pressure manifesting as true papilloedema.à  Long-standing axonal compression or papilloedemaà  can lead to secondary optic atrophy.à  Theà  accumulation of GAG in ganglion cells of retina can lead to axonal degeneration and optic atrophy.  Optic nerve involvement is more commonly seen in typesà  I, II, VIà  andà  VII,à  as the majorà  Ã  GAGsà  in optic nerve and lamina cribrosa are dermatan sulfate and chondritin sulfate.  Optic nerve involvement is less with type III,à  as heparan sulfate is located in the margins of lamina cribrosa,à  and in type IV,à  as keratan sulfate is not present in the optic nerve head in human.à    4.à  Glaucoma  The human trabecular meshwork contains chondroitin sulfate, keratan sulfate, heparan sulfateà  andà  dermatan sulfate.à  Theà  accumulation ofà  Ã  GAGà  in the anterior segment structures can lead toà  theà  narrowing of angle resulting in acute angle closure and chronic angle closure glaucoma. Anterior segmentà  optical coherence tomographyà  (OCT)à  imaging in mucopolysacchridosis suggests crowded anterior segment and increased corneal thickness in type VI thanà  inà  type I.à  Theà  accumulation of GAG in trabecular cells can lead to features similar to open-angle glaucoma.à  Theà  measurement of IOP by Goldmann applanation tonometer may be falsely high due to increased corneal thickness and corneal hysteresis.à  Theà  visualization of angle by gonioscopy may be compromised due to corneal clouding,à  thus posing difficulty in differentiating open angle from closed angle.à  Theà  monitoring of progression and severity of glaucomatous optic neuropathy may be    compromised by corneal clouding and discà  oedema. Anterior segment OCT is a valuable tool inà  theà  assessment of angle, particularly in patients with corneal clouding. Ocular responseà  Ã  analyserà  can be usedà  for theà  accurate measurement of IOP in these cases.  5. Retina  Heparan sulfate, dermatan sulfate, chondroitin sulfate and hyaluronan are present throughout the retina and choroid. Heparan sulfate is particularly located inà  theà  basement membrane containing structures, the RNFL and RPE. Keratan sulfate is absent inà  theà  retina and choroid.à  Ã  GAGsà  are integral components ofà  theà  basement membrane of retinal microvasculature,à  and heparan sulfate is the predominant variety. Tapetoretinal degeneration has been reported in MPS typesà  I,à  Ã  II,à  Ã  III andà  Ã  IV.  6.à  Sclera  Scleral thickening may lead toà  theà  uveal effusion syndrome.  Suggested Reading  1.à  Villas-Boas FS, Fernandes Filho DJ, Acosta AX.à  Ocular findings in patients with mucopolysaccharidosis.à  Arq Bras Oftalmolà  2011;74(6):430ââ¬â434.  2.à  Viestenz A, Shin YS, Viestenz A, Naumann GO.à  Ocularà  manifestation ofà  mucopolysaccharidosis I-S (Scheiesà  syndrome).à  Klin Monbl Augenheilkdà  2002;219(10):745ââ¬â748.    
Subscribe to:
Post Comments (Atom)
 
 
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.